Dana-Farber/New Hampshire Oncology-Hematology — Londonderry, New Hampshire

Dana-Farber/New Hampshire Oncology-Hematology is a clinical research site located in Londonderry, New Hampshire, United States 03053.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana-Farber/New Hampshire Oncology-Hematology has participated in 11 clinical trials with 5 currently active.

Therapeutic areas: Breast Cancer, Metastatic Breast Cancer, Early Stage Breast Cancer.

Sponsors: Dana-Farber Cancer Institute, American Society of Clinical Oncology.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber/New Hampshire Oncology-Hematology?

Dana-Farber/New Hampshire Oncology-Hematology has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber/New Hampshire Oncology-Hematology conducted?

Dana-Farber/New Hampshire Oncology-Hematology has 11 clinical trials on record, with 5 currently active. Their work covers Breast Cancer, Metastatic Breast Cancer, Early Stage Breast Cancer.

Is Dana-Farber/New Hampshire Oncology-Hematology accredited by Crixeo Health?

Yes — Dana-Farber/New Hampshire Oncology-Hematology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Dana-Farber/New Hampshire Oncology-Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.